Skip to content
NHS South West London logo

Main Navigation

  • Home
  • About us
  • Your area
    • Croydon
  • Policies
    • Commissioning
    • Individual Funding Request (IFR)
    • Pharmaceutical Offers
    • Prescribing: Hospital or specialist only medicines
    • Prescribing: Interface policy
    • Prescribing: Agreement for shared care, transfer of care and notification of initiation
    • Position Statements
  • Clinical Guidance
    • 1. Gastro-intestinal System
    • 2. Cardiovascular System
    • 3. Respiratory System
    • 4 Central Nervous System
    • 5. Infections
    • 6. Endocrine System
    • 7. Obstetric, Gynaecology, and Urinary Tract Disorders
    • 9. Nutrition and Blood
    • 10. Musculoskeletal & Joint Diseases
    • 11. Eye
    • 13. Skin
    • 14. Vaccines and Immunisations
    • 26. A5: Wound Management
    • Renal
    • Self Care Guidance for Clinicians
    • Pharmacy First Service
  • Information for patients
    • Discharge Medicines Service (DMS)
    • Managing your Medicines and Appliances
    • Medicines of limited clinical value
    • Self Care
  • Contact us
  • Inflammatory Bowel Disease
  • Pancreatic Enzyme Replacement Therapy (PERT)
  • Stoma Care

Inflammatory Bowel Disease

Inflammatory Bowel Disease Drug Pathway

Janus Kinase (JAK) Inhibitors and MHRA Safety Warnings

Sequential interleukin (IL) inhibitor – Proposal for use

Website managed by SWL Medicines Optimisation Document Governance Team
NHS South West London Integrated Care Board
120 The Broadway
Wimbledon SW19 1RH
  • Privacy policy
  • Cookie policy
  • Accessibility statement
  • Google Translate
Site designed by NECS Design Solutions